A decision-analysis tool for benefit-risk assessment of nonprescription drugs.
about
Assessing the benefit-risk for new drugs: are the FDA's Endocrinologic and Metabolic Drugs Advisory Committee and the Division of Metabolism and Endocrinology Products in sync?Assessing the value of healthcare interventions using multi-criteria decision analysis: a review of the literature.Balancing benefit and risk of medicines: a systematic review and classification of available methodologies.Structured Frameworks to Increase the Transparency of the Assessment of Benefits and Risks of Medicines: Current Status and Possible Future Directions.Use of multicriteria decision analysis for assessing the benefit and risk of over-the-counter analgesics.
P2860
A decision-analysis tool for benefit-risk assessment of nonprescription drugs.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A decision-analysis tool for benefit-risk assessment of nonprescription drugs.
@en
type
label
A decision-analysis tool for benefit-risk assessment of nonprescription drugs.
@en
prefLabel
A decision-analysis tool for benefit-risk assessment of nonprescription drugs.
@en
P2860
P356
P1476
A decision-analysis tool for benefit-risk assessment of nonprescription drugs.
@en
P2093
Eric P Brass
Ragnar Lofstedt
P2860
P304
P356
10.1002/JCPH.22
P50
P577
2013-02-04T00:00:00Z